Article
Systemic Inflammatory Markers of Survival in Epidermal Growth Factor-Mutated Non-Small-Cell Lung Cancer: Single-Institution Analysis, Systematic Review, and Meta-analysis.
Clinical lung cancer - 1 Sept 2021
Chan Sze Wah Samuel, Smith Elliot, Aggarwal Reenika, Balaratnam Karmugi, Chen RuiQi, Hueniken Katrina, Fazelzad Rouhi, Weiss Jessica, Jiang Shirley, Shepherd Frances A, Bradbury Penelope A, Sacher Adrian G, Leighl Natasha B, Xu Wei, Brown M Catherine, Eng Lawson, Liu Geoffrey
Abstract excerpt
BACKGROUND: Systemic inflammatory response (SIR) may influence prognosis in epidermal growth factor receptor (EGFR)-mutated (m) non-small-cell lung cancer (NSCLC). Pretreatment SIR markers (neutrophil-to-lymphocyte ratio [NLR], platelet-to-lymphocyte ratio, lymphocyte-to-monocyte ratio [LMR], lactate dehydrogenase [LDH], and lung immune prognostic index [LIPI]) were assessed as prognostic factors in NSCLC...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.